MaxLinear officer sells 4,118 shares

MAXLINEAR, INC Corporate Controller & PAO Connie H. Kwong reported an open-market sale of 4,118 shares of Common Stock at $58.00 per share on April 29, 2026.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

MAXLINEAR, INC Corporate Controller & PAO Connie H. Kwong reported an open-market sale of 4,118 shares of Common Stock at $58.00 per share on April 29, 2026. Following this sale, she directly holds 48,947 shares of MaxLinear common stock.

Insider Trade Summary

Net Seller: 4,118 shares

Net Sell 1 txn

Insider Kwong Connie H.

Role Corporate Controller & PAO

Sold 4,118 shs ($239K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,118	$58.00	$239K

Holdings After Transaction: Common Stock — 48,947 shares (Direct)

Key Figures

Shares sold: 4,118 shares Sale price: $58.00 per share Shares held after transaction: 48,947 shares +1 more

4 metrics

Shares sold 4,118 shares Open-market sale of MaxLinear common stock

Sale price $58.00 per share Price for the 4,118 shares sold

Shares held after transaction 48,947 shares Direct MaxLinear common stock holdings post-sale

Net shares sold 4,118 shares Net change in direct holdings from this Form 4

Key Terms

open-market sale, Common Stock, Corporate Controller & PAO

3 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Corporate Controller & PAO financial

"officer_title: "Corporate Controller & PAO""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Connie H. Kwong report at MaxLinear (MXL)?

Connie H. Kwong reported an open-market sale of 4,118 shares of MaxLinear common stock at $58.00 per share. The transaction reflects a net reduction of 4,118 shares in her direct holdings as disclosed in the Form 4 filing.

What is Connie H. Kwong’s role at MaxLinear (MXL)?

Connie H. Kwong serves as MaxLinear’s Corporate Controller & Principal Accounting Officer. This senior finance role oversees accounting and financial reporting, making her transactions in MaxLinear common stock relevant for investors tracking insider trading activity at the company.

How many MaxLinear (MXL) shares did the insider sell and at what price?

The insider sale covered 4,118 shares of MaxLinear common stock at a price of $58.00 per share. The transaction was classified as an open-market sale, meaning the shares were sold directly in the market or a similar private transaction.

How many MaxLinear (MXL) shares does Connie H. Kwong hold after the sale?

After the reported sale, Connie H. Kwong directly holds 48,947 shares of MaxLinear common stock. This post-transaction balance, disclosed in the Form 4, provides context on her remaining equity position with the company following the open-market sale.

Was the MaxLinear (MXL) insider transaction a buy or sell action?

The transaction was a sell action, specifically an open-market sale of common stock. Form 4 data classify it under transaction code “S” and transaction_direction “sell,” confirming it reduced Connie H. Kwong’s directly held MaxLinear share count by 4,118 shares.

Did the MaxLinear (MXL) filing show any derivative security exercises?

No derivative security exercises were reported in this Form 4. The filing lists only a non-derivative transaction in MaxLinear common stock, with derivativeSummary showing no remaining derivative positions or option exercises associated with the reported transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/30/2026 - 04:30 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kwong Connie H.

(Last)

(First)

(Middle)

C/O MAXLINEAR, INC.

5966 LA PLACE COURT, SUITE 100

(Street)

CARLSBAD

CALIFORNIA

92008

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MAXLINEAR, INC [ MXL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Corporate Controller & PAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/29/2026		S		4,118	D	$58	48,947	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

Remarks:

	/s/ Connie Kwong	04/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR